Please login to the form below

Not currently logged in
Email:
Password:

Lindsay Rocco to lead corporate communications at Dendreon

Joins from agency Rx Mosaic Health

Lindsay Rocco, DendreonDendreon has appointed Rx Mosaic Health's Lindsay Rocco to executive VP, corporate communications.

The US biotech, which markets prostate cancer vaccine Provenge (sipuleucel-T), said Rocco will be responsible for all communications functions of the company, reporting directly to chair, president and CEO John Johnson.

Rocco was most recently senior VP at healthcare communications agency Rx Mosaic Health, a position she held since February 2010.

She has previous communications experience within the industry too, serving as director, public affairs at Roche, prior to her time at Rx Mosaic Health.

“Lindsay is a seasoned communicator with a deep understanding of the oncology space and a true passion for Dendreon's mission to help advanced prostate cancer patients lead longer and better lives,” said Johnson.

“Lindsay's energy and expertise in healthcare communications makes her an ideal addition to our leadership team.”

15th November 2012

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics